- No mention of a minimum cap.
- They will review 100-200 companies and narrow this down.
- Focuses on companies developing cutting-edge therapies and technologies
- 20% Healthcare tech/AI/Software & 80% Biotech/medical devices/diagnostics
- Pre Clinical (10%), Phase 1 (10/20%), Phase 2/3 (25/35%), Commercial Stage (40/50%)
- Mentions they may invest up to a third of capital into micro/small cap listed
- No mention of a minimum cap.- They will review 100-200...
-
- There are more pages in this discussion • 360 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add EYE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
24.0¢ |
Change
-0.010(4.00%) |
Mkt cap ! $54.91M | |||
| Open | High | Low | Value | Volume |
| 25.0¢ | 25.5¢ | 24.0¢ | $48.87K | 198.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 385197 | 24.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 24.5¢ | 14358 | 1 |
View Market Depth
| Last trade - 16.10pm 24/07/2024 (20 minute delay) ? |
| EYE (ASX) Chart |